Looks like no one added any tags here yet for you.
according to the code of ethics for pharmacists, telling the truth fro the benefit of patients and for the correct reporting of medication errors is ..
Veracity
What was the disaster that led to the Food, Drug, and Cosmetics Act of 1939?
Sulfanilamide
-enacted to ensure patient confidentiality and privacy;adulterated drugs
altered and causing an undesirable effect;misbranded drugs
-detailed document pertaining to a specific drug;
Pure Food & Drug Act of 1906
passed for fed. inspection of meat and forbade the manufacture, sale or transport of adulterated food products. Was inadequate because it did not: -cover cosmetics -grant gov't authority to ban unsafe drugs -prohibit mfg from making false statements -require labeling to identify contents
Food, Drug and Cosmetic Act of 1938 (FDCA)
-req. to prove drugs were safe -had to have warnings and directions for use -new drugs req to be tested -req 'labeling' -regulated who could prescribe legend drugs
legend drugs
drugs available by prescription only
Durham-Humphrey Amendment of 1951
AKA - Prescription Drug Amendment -required that prescription drugs bear the legend, 'Caution: Federal law prohibits dispensing without a prescription.' -Later substituted 'Rx only'
Kefauver-Harris Amendment of 1962
AKA - Drug Efficacy Amendment -focused on drug manuf. accountability for the efficacy, or effectiveness of drugs -Good manuf. practices (GMP) established -Req to supply proof of effectiveness -Advertising placed under FDA -Procedure for drugs established
Comprehensive Drug Abuse Prevention and Control Act of 1970
AKA - Controlled Substance Act of 1970 -est. the Drug Enforcement Admin (DEA) -est. five classes (schedules) of controlled substance by potential for abuse
Schedule I (C-I)
-high potential for abuse -no currently accepted medical use -illegal drugs -heroin, LSD, marijuana
Schedule II (C-II)
-high potential for abuse -accepted medical use -may lead to severe dependence -cocaine, morphine, Ritalin
Schedule III (C-III)
-less potential for abuse -accepted medical use -moderate physical dependence -Vicodin, Lortab, Tylenol 3, anabolic steroids -5 refills within 6 months
Schedule IV (C-IV)
-low potential for abuse -accepted medical use -limited dependence -Valium, Librium -5 refills within 6 months
Schedule V (C-V)
-low potential for abuse -accepted medical use -limited dependence -Lomotil -can be refilled for up to one year
Poison Prevention Packaging Act of 1970 (PPPA)
all legend and controlled substances must be dispensed in a childproof container
Occupational Safety and Health Act of 1970 (OSHA)
created to ensure worker and workplace safety
Drug Listing Act of 1972
-amended the Food, Drug & Cosmetic Act to require manufactures, etc to register their products with the FDA -each drug assigned a unique and permanent product code known as National Drug Code (NDC)
Orphan Drug Act of 1983
-to stimulate development of drugs for rare diseases -7 year market exclusivity -tax credit of 50% of cost of conducting human trials -fed research grants for clinical testing -exemption from drug application or user fees
Prescription Drug Marketing Act of 1987
marketing practices including distribution of free sample, coupons for drugs at no cost or low cost, etc
Anabolic Steroid Control Act of 1990
placed steroids on Schedule III list
Omnibus Budget Reconciliation Act of 1990
AKA OBRA -focused on federal funding of Medicare and Medicaid programs -created increased need for pharmacy techs -mandated that pharmacists perform drug utilization reviews (DURs) -offer counseling to patients
Dietary Supplement Health and Education Act of 1994
-define dietary supplements & ingredients -literature displayed where sold -req ingredient & nutrition labeling
Health Insurance Portability and Accountability Act of 1996
AKA - HIPAA -enacted to ensure patient confidentiality and privacy
adulterated drugs
altered and causing an undesirable effect
misbranded drugs
a drug that has been misleadingly or fraudulently labeled.
medical device
any instrument or apparatus used in the diagnosis, prevention, monitoring, treatment or alleviation of disease
monograph
-commonly referred to as 'package inserts' -detailed document pertaining to a specific drug